Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
21,818,652
-
Share change
-
-2,013,559
-
Total reported value
-
$3,714,048
-
Put/Call ratio
-
114%
-
Price per share
-
$0.1702
-
Number of holders
-
31
-
Value change
-
-$437,670
-
Number of buys
-
12
-
Number of sells
-
18
Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q3 2022
As of 30 Sep 2022 iBio, Inc. - Common Stock (IBIO) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,818,652 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Ergoteles LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, GROUP ONE TRADING, L.P., and EDMOND DE ROTHSCHILD HOLDING S.A..
This table shows 33 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.